SEC Form 4 · accession 0001209191-18-043113
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yoram Palti
Officer — Chief Technology Officer · Director
Period of report
Jul 16, 2018
Accepted (ET)
Jul 18, 2018 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jul 16, 2018 | S$0 | 2,315 | — | D | 1,098,739 | I | Bennett Limited |
| Ordinary SharesF3,F2 | Jul 16, 2018 | S$0 | 27,685 | — | D | 1,071,054 | I | Bennett Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,315 shares in multiple trades at prices ranging from $36.00 to $36.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F2Professor Palti shares voting and investment power for the shares held by Bennett Limited.
- F3On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,685 shares in multiple trades at prices ranging from $35.00 to $35.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.